Answers are grounded in this paper and cite their sources.
Beta-catenin is a multifunctional protein that is both an integral component of adherens junctions and a pivotal member of a signal transduction pathway. The cytoplasmic pool of beta-catenin, which participates in signal transduction, is highly regulated. Binding to the adenomatous polyposis coli tumor suppressor protein can stimulate the degradation of beta-catenin, whereas signaling initiated by the extracellular Wnt-1 oncoprotein or selected mutations in beta-catenin itself results in the accumulation of higher levels of beta-catenin in the cytoplasm. A variety of experiments from several model systems have converged to elucidate the mechanisms involved in this regulation as well as the downstream effectors of beta-catenin. These studies have recently been extended to demonstrate that deregulation of this pathway contributes to cancer in humans.
No takes yet. Share an insight, caveat, or question.
Bullions et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: